SIGMAR1 and fragile X syndrome: Blarcamesine is a Sig-1R agonist (Villard et al., 2011), and the important role of Sig-1R in calcium homeostasis and synaptic function (Su et al., 2016; Schmidt and Kruse, 2019) makes blarcamesine a potential candidate for FXS.